[Congressional Record Volume 158, Number 100 (Friday, June 29, 2012)]
[Extensions of Remarks]
[Page E1202]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




     THE ACCOMPLISHMENTS OF ARIZONA'S TGEN ON ITS 10TH ANNIVERSARY

                                 ______
                                 

                            HON. JEFF FLAKE

                               of arizona

                    in the house of representatives

                         Friday, June 29, 2012

  Mr. FLAKE. Mr. Speaker, I rise today to acknowledge the achievements 
in the field of biomedical research of the Translational Genomics 
Research Institute, known as TGen, over the last decade.
  Located in Phoenix, TGen applies the science of genomics, or the 
study of the human genetics, to finding cures for neurological 
disorders and diseases such as cancer and diabetes.
  When TGen was founded in 2002, Arizona's state and local leaders were 
excited by the promise of the many novel scientific discoveries that 
could be made through TGen.
  But what was most exciting was that these discoveries made possible 
through further research into the human genome would translate into 
immediate and effective benefits for doctors and especially patients.
  By partnering with entities at the forefront of medical discoveries 
like the Mayo Clinic and Scottsdale Healthcare, TGen for 10 years has 
focused on utilizing genomic analyses to improve patient treatments. 
Whether it's sequencing anthrax or the plague; finding new clues to 
Alzheimer's disease; or leading new research partnerships addressing 
pediatric and canine cancers, TGen's research has changed patients' 
lives.
  In addition to making critical contributions to the scientific and 
medical fields, over the past 10 years, TGen has made many 
contributions to Arizona's economy in the forms of investment and 
private-sector job creation. Investment into TGen and the biosciences 
spurred growth across the state, and spurred the launch of the Critical 
Path Institute and Bio5 in southern Arizona; Arizona State University's 
Biodesign Institute and a northern Phoenix bio campus; TGen North; and 
expansion of W.L. Gore in northern Arizona.
  On its 10th anniversary, I applaud TGen's president, Dr. Jeffrey 
Trent, and the scientists at TGen for their commitment to make a 
difference for medical patients and their contributions to creating 
innovative research for Arizona.

                          ____________________